Praetego Awarded $0.3M by National Eye Institute to Advance Novel Oral Drug for Diabetic Retinopathy
/PRNewswire/ -- (https://www.praetego.com/) Praetego Inc, a pharmaceutical company protecting patients from neurodegenerative diseases related to aging, is...
Source: prnewswire.com